Domestic Manufacturers Aim to Realize Faster Market Share Gains for First Generics

The domestic pharmaceutical firms are increasing their efforts to gain the first-hand competitive advantages by executing faster introductions of the first generic products in the market.

The firms collectively make strategic observations on the original drugs and their expected patent and postmarketing surveillance (PMS) expiration periods, and submit advance market approval requests for th...